CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Grant or award Director acquired 15,789 shares (grant or award)
- 4 Grant or award EVP, R&D and CMO acquired 15,000 shares (grant or award)
- 4 Grant or award SVP, Fin/Treas, Chief Actg Off acquired 3,300 shares (grant or award)
- 4 Grant or award President & CEO acquired 58,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,026 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, R&D and CMO gave up 5,880 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 23,516 shares (to pay taxes)
- 4 Grant or award Director acquired 19,480 shares (grant or award)
- 4 Grant or award Director acquired 19,480 shares (grant or award)
- 4 Grant or award Director acquired 19,480 shares (grant or award)
- 4 Grant or award Director acquired 19,480 shares (grant or award)
- 4 Grant or award Director acquired 19,480 shares (grant or award)
- 4 Shares withheld for taxes EVP, R&D and CMO gave up 2,908 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 397 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,030 shares (to pay taxes)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
Page 2 of 33 · 648 filings